WeVote
Log In

Bill

Bill

HB 17

Protecting Patient Access to Physician-Administered Drugs Act; create.

2025 Regular Session Introduced by Jeff Hale and 1 co-sponsor

Mississippi law protects patient access to physician-administered drugs by limiting insurer/PBM restrictions on these clinical medications.

Law W/out Governor's Signature
#drugpolicy #insurance
0
WeVote Research Nonpartisan
Bill Summary · HB 17

Legislative bill overview

HB 17 protects patient access to physician-administered drugs by establishing legal protections for patients and providers regarding these medications. The bill became law without the Governor's signature on March 21, 2025, following passage through the Mississippi legislature.

Why is this important

Physician-administered drugs—medications given directly by doctors in clinical settings rather than dispensed by pharmacies—can face coverage or access restrictions from insurers or pharmacy benefit managers. This bill ensures patients retain access to treatments their physicians deem medically necessary, which directly affects treatment options for conditions ranging from cancer to rheumatologic diseases.

Potential points of contention

  • Insurance cost implications: Restrictions on physician-administered drugs sometimes reflect payer efforts to control costs; this bill may increase insurance expenses or premiums
  • Scope ambiguity: The bill's specific protections and which drugs/situations qualify aren't detailed in available summaries, leaving implementation questions
  • PBM authority limits: Pharmacy benefit managers may oppose restrictions on their ability to manage drug formularies and prior authorization processes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.